Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial-Reference-Cited by-同舟云学术

Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial

Published:2019-02 Issue:2 Volume:20 Page:297-310
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cella David,Grünwald Viktor,Escudier Bernard,Hammers Hans J,George Saby,Nathan Paul,Grimm Marc-Oliver,Rini Brian I,Doan Justin,Ivanescu Cristina,Paty Jean,Mekan Sabeen,Motzer Robert J

Funder

Memorial Sloan Kettering Cancer Center Support

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

2. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

3. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study;Heng;Lancet Oncol,2013

4. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009

5. Pazopanib versus sunitinib in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2013

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma;Journal of Clinical Oncology;2024-08-10

2. Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning;Heliyon;2024-08

3. Design and Rationale of the Outcomes Database to Prospectively Assess the Changing Therapy Landscape in Renal Cell Carcinoma Registry: A Multi-institutional, Prospective Study of Patients with Metastatic Renal Cell Carcinoma;European Urology Open Science;2024-08

4. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer;Current Treatment Options in Oncology;2024-07-27

5. Role of Immune Cells in Mediating the Effect of Gut Microbiota on Renal Cell Carcinoma;2024-07-18